Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2010

Study Completion Date

June 30, 2011

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Pegylated liposomal doxorubicin

30 mg/m2 IV on Day 1 of each 28 day cycle

DRUG

Carboplatin

AUC=5 on Day 1 of each 28 day cycle

DRUG

trastuzumab

4 mg/kg on Days 1 and 15 of each cycle(loading dose of 8 mg/kg on Day 1 of Cycle 1 only)

Trial Locations (57)

10016

Ruth Oratz MD, New York

12208

New York Oncology Hematology, PC, Albany

18704

Medical Oncology Associates, Kingston

21044

Maryland Oncology Hematology, PA, Columbia

21157

Flavio Kruter, MD, PA, Westminster

22031

Fairfax Northern VA Hem-Onc PC, Fairfax

23502

Virginia Oncology Associates, Norfolk

24153

Onc and Hem Associates of SW VA, Inc, Salem

27511

Raleigh Hematology Oncology Associates, Cary

34474

Ocala Oncology Center, Ocala

34655

Florida Cancer Institute, New Port Richey

35205

Birmingham Hematology and Oncology, Birmingham

45409

Greater Dayton Cancer Center, Kettering

46227

Central Indiana Cancer Centers, Indianapolis

55404

Minnesota Oncology Hematology, PA, Minneapolis

60611

Hematology Oncology Associates of IL, Chicago

60714

Cancer Care & Hematology Specialists of Chicagoland, PC, Niles

65201

Missouri Cancer Associates, Columbia

66210

Kansas City Cancer Centers-Southwest, Overland Park

75042

Texas Oncology, PA, Garland

75067

Lake Vista Cancer Center, Lewisville

75090

Texas Cancer Center-Sherman, Sherman

75150

Texas Cancer Center of Mesquite, Mesquite

75230

Texas Cancer Center at Medical City, Dallas

75231

Texas Oncology, PA, Dallas

75237

The TexasCancer Center, Dallas

75246

Texas Oncology, PA, Dallas

75460

Paris Regional Cancer Center, Paris

75601

Longview Cancer Center, Longview

75702

Tyler Cancer Center, Tyler

76014

Texas Cancer Center, Arlington

76022

Texas Oncology, PA-Bedford, Bedford

76104

Texas Oncology, PA, Fort Worth

76210

Texas Cancer Center-Denton, Denton

76712

Texas Oncology Cancer Care and Research Center-Waco, Waco

77024

Texas Oncology, PA, Houston

77479

Texas Oncology Cancer Center-Sugar Land, Sugar Land

77598

Texas Oncology, P.A., Webster

77702

Mamie McFaddin Ward Cancer Center, Beaumont

78229

HOAST-Medical Dr., San Antonio

78503

South Texas Cancer Center-McAllen, McAllen

79106

Texas Oncology, P.A.-Amarillo, Amarillo

79606

Texas Cancer Center - Abilene (South), Abilene

79701

Alison Cancer Center, Midland

79761

West Texas Cancer Center, Odessa

79915

El Paso Cancer Treatment Ctr, El Paso

80220

Rocky Mountain Cancer Center-Rose, Denver

85012

Hematology Oncology Associates, Phoenix

86336

Northern AZ Hematology & Oncology Associates-Sedona, Sedona

87505

New Mexico Cancer Care Associates, Santa Fe

89109

Comprehensive Cancer Centers of Nevada, Las Vegas

97401

Willamette Vallejy Cancer Center, Eugene

98026

Puget Sound Cancer Center-Edmonds, Edmonds

98133

Puget Sound Cancer Center-Seattle, Seattle

98684

Northwest Cancer Specialists-Vancouver, Vancouver

98902

Yakima Valley Mem Hosp/North Star Lodge, Yakima

99218

Cancer Care Northwest-North, Spokane

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ortho Biotech, Inc.

INDUSTRY

collaborator

Tibotec Pharmaceutical Limited

INDUSTRY

lead

US Oncology Research

INDUSTRY